AlloVir
Ann Leen is an accomplished professional with extensive experience in the field of hematology and oncology. Currently serving as an Associate Professor in the Department of Pediatrics at Baylor College of Medicine since August 2013, Ann Leen also holds the position of Co-Founder and Chief Scientific Officer at ViraCyte, LLC since January 2013. Educational qualifications include a Doctor of Pharmacy (PharmD) obtained from the University of Birmingham and a Bachelor's degree from University College Cork. Additionally, Ann Leen has completed a Postdoctoral Fellowship at Baylor College of Medicine and worked as a Research Associate at the CRC Institute for Cancer Studies at the University of Birmingham.
AlloVir
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.